Search Results
Aug 14, 2026, 11:45 ET WallachBeth Capital Announces Closing of bioAffinity Technologies $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today announced that it has closed its previously announced
More news about: WallachBeth Capital LLC
Aug 13, 2026, 10:00 ET WallachBeth Capital Announces bioAffinity Technologies Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today announced that it has entered into a securities purchase
More news about: WallachBeth Capital LLC
Jun 18, 2026, 14:54 ET WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases,
More news about: WallachBeth Capital LLC
Jun 17, 2026, 10:41 ET WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.2 Million Offering
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases,
More news about: WallachBeth Capital LLC
Oct 09, 2025, 14:00 ET WallachBeth Capital Announces The Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
LLC, a leading provider of capital markets and institutional execution services, announced today that bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW) a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, has closed the previously announced definitive
More news about: WallachBeth Capital LLC
Oct 08, 2025, 16:15 ET WallachBeth Capital Announces bioAffinity Technologies Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
LLC, a leading provider of capital markets and institutional execution services, announced today that bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW) a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today announced that it has entered into
More news about: WallachBeth Capital LLC
Sep 30, 2025, 12:44 ET WallachBeth Capital Announces Closing of bioAffinity Technologies Public Offering for $4.8m
LLC, a leading provider of capital markets and institutional execution services, announced today that bioAffinity Technologies, Inc. (NASDAQ: BIAF and BIAFW) a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer has closed its previously announced public
More news about: WallachBeth Capital LLC
Sep 29, 2025, 17:59 ET WallachBeth Capital Announces Pricing of bioAffinity Technologies Public Offering for $4.8m
bioAffinity Technologies, Inc. (NASDAQ: BIAF and BIAFW) a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer has priced a public offering of securities
More news about: WallachBeth Capital LLC